| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 2.452 | 14.319 | 29.672 | 30.951 | 29.259 | 27.746 | 36.027 | 44.693 | 60.153 | 61.949 |
| Total Income - EUR | 2.452 | 14.319 | 29.672 | 30.951 | 29.259 | 27.746 | 36.041 | 45.316 | 61.011 | 62.867 |
| Total Expenses - EUR | 2.593 | 7.430 | 13.101 | 12.713 | 13.635 | 12.160 | 11.178 | 12.530 | 19.425 | 25.976 |
| Gross Profit/Loss - EUR | -141 | 6.890 | 16.571 | 18.238 | 15.624 | 15.586 | 24.864 | 32.786 | 41.587 | 36.891 |
| Net Profit/Loss - EUR | -214 | 6.556 | 16.274 | 17.928 | 15.331 | 15.119 | 24.510 | 32.342 | 40.989 | 35.043 |
| Employees | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 2 |
Check the financial reports for the company - Dr. Baldea & Dr. Baldea Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 2.728 | 1.807 | 997 | 609 | 905 | 1.296 | 2.545 |
| Current Assets | 372 | 7.063 | 17.028 | 18.054 | 15.103 | 14.806 | 24.605 | 34.105 | 42.137 | 35.342 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 247 | 0 | 0 |
| Receivables | 0 | 1.444 | 2.512 | 2.536 | 332 | 0 | 0 | 24.655 | 5.139 | 2.658 |
| Cash | 372 | 5.619 | 14.516 | 15.518 | 14.771 | 14.806 | 24.605 | 9.202 | 36.998 | 32.684 |
| Shareholders Funds | 68 | 6.623 | 16.327 | 17.980 | 15.382 | 15.168 | 24.559 | 32.391 | 41.037 | 35.091 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 305 | 440 | 701 | 2.801 | 1.528 | 634 | 656 | 2.619 | 2.396 | 2.796 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dr. Baldea & Dr. Baldea Srl